At a glance
ClinicalIndex Comparison RecordN/ACompleted· 450 enrolled
Drug / intervention
DCTclockdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of DCTclock™ as a Cognitive Assessment Aid
In Brief
A clinical study evaluating DCTclock for Cognitive Function. Completed, enrolled 450 participants across 1 site.
Detailed Summary
The overall objective of this study is to demonstrate the safety and effectiveness of DCTclock as an adjunctive tool for use by clinicians to evaluate cognitive function in adults aged 55-95.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCognitive Function
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
First PostedAug 2017
Primary CompletionNov 2017
TodayJul 2026
First PostedAug 3, 2017
Enrollment StartJul 11, 2017
Primary CompletionNov 21, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 8.9 years ago
Interventions
DCTclockdevice
DCTclock is a quick and non-invasive test that measures cognitive function based on a computerized algorithmic analysis of the entire drawing process and output of a well-established cognitive assessment called The Clock Drawing Test (CDT).